Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with View All

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
40 Q3 2021 ACACIA ORAL POWDER 1231.00 mg Correction
40 Q4 2021 ACACIA ORAL POWDER 800.00 mg Correction
137 Q3 2021 ISOOCTYL ACRYLATE/ACRYLAMIDE/VINYL ACETATE COPOLYMER, KOLLIDON VA 64 POLYMER TOPICAL SPONGE 5.40 %w/w Correction
137 Q4 2021 ACRYLATES COPOLYMER TOPICAL SOLUTION 5.40 %w/w Correction
331 Q3 2021 CITRIC ACID MONOHYDRATE BUCCAL FILM, SOLUBLE 0.69 mg Correction
331 Q4 2021 ANHYDROUS CITRIC ACID BUCCAL FILM, SOLUBLE 3 mg Correction
2207 Q3 2021 ERYTHROSINE SODIUM ANHYDROUS ORAL CAPSULE 0.42 mg Correction
2207 Q4 2021 ERYTHROSINE SODIUM ANHYDROUS ORAL CAPSULE 0.01 mg Correction
2817 Q3 2021 FLAVOR MIXED FRUIT PFC-9970 ORAL GRANULE, FOR SUSPENSION 350.00 mg/ 5.00 ml Correction
2817 Q4 2021 FLAVOR MIXED FRUIT PFC-9970 ORAL GRANULE, FOR SUSPENSION 17.50 mg/ 5.00 ml Correction
3099 Q3 2021 GLYCERIN TOPICAL CLOTH 50.00 mg Correction
3099 Q4 2021 GLYCERIN TOPICAL CLOTH 0.05 mg/mg Correction
3498 Q3 2021 HYDROGENATED SOYBEAN LECITHIN INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL 9.58 mg/ml Correction
3498 Q4 2021 HYDROGENATED SOYBEAN PHOSPHATIDYLCHOLINE INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL 9.58 mg/ml Correction
3596 Q3 2021 HYDROXYPROPYL CELLULOSE (1600000 WAMW) ORAL TABLET, CHEWABLE 20 mg Correction
3596 Q4 2021 HYDROXYPROPYL CELLULOSE (1600000 WAMW) ORAL TABLET, CHEWABLE 10 mg Correction
3691 Q3 2021 HYPROMELLOSE 2208 (100000 MPA.S) ORAL TABLET, FILM COATED 536.80 mg Correction
3691 Q4 2021 HYPROMELLOSE 2208 (100 MPA.S) ORAL TABLET, FILM COATED 10.00 mg Correction
3711 Q3 2021 HYPROMELLOSE 2208 (3 MPA.S) ORAL TABLET, EXTENDED RELEASE 184.25 mg Correction
3711 Q4 2021 HYPROMELLOSE 2208 (3 MPA.S) ORAL TABLET, EXTENDED RELEASE 85.50 mg Correction
5607 Q3 2021 OPADRY YS-1-8325 BEIGE ORAL TABLET 48 mg Correction
5607 Q4 2021 OPADRY YS-1-8325 BEIGE ORAL TABLET 16.00 mg Correction
6279 Q3 2021 POLYETHYLENE GLYCOL 8000 ORAL TABLET, MULTILAYER, EXTENDED RELEASE 4.30 mg Correction
6279 Q4 2021 POLYETHYLENE GLYCOL 8000 ORAL TABLET, MULTILAYER, EXTENDED RELEASE 2.50 mg Correction
6559 Q3 2021 POLYVINYL ACETATE ORAL TABLET 19.24 mg Correction
6559 Q4 2021 POLYVINYL ACETATE ORAL TABLET 7.00 mg Correction
6847 Q3 2021 PPG-11 STEARYL ETHER TOPICAL AEROSOL, FOAM 5.00 %w/w Correction
6847 Q4 2021 POLYPROPYLENE GLYCOL 11 STEARYL ETHER TOPICAL AEROSOL, FOAM 5.00 %w/w Correction
6848 Q3 2021 PPG-11 STEARYL ETHER TOPICAL SUSPENSION 16.00 %w/w Correction
6848 Q4 2021 POLYPROPYLENE GLYCOL 11 STEARYL ETHER TOPICAL SUSPENSION 16.00 %w/w Correction
6851 Q3 2021 PPG-15 STEARYL ETHER TOPICAL GEL 2.00 %w/w Correction
6851 Q4 2021 POLYPROPYLENE GLYCOL 15 STEARYL ETHER TOPICAL GEL 2.00 %w/w Correction
6852 Q3 2021 PPG-15 STEARYL ETHER TOPICAL OINTMENT 15.00 %w/w Correction
6852 Q4 2021 POLYPROPYLENE GLYCOL 15 STEARYL ETHER TOPICAL OINTMENT 15.00 %w/w Correction
6853 Q3 2021 PPG-15 STEARYL ETHER TOPICAL SUSPENSION 16.00 %w/w Correction
6853 Q4 2021 POLYPROPYLENE GLYCOL 15 STEARYL ETHER TOPICAL SUSPENSION 16.00 %w/w Correction
6873 Q3 2021 POVIDONE K15 TOPICAL SYSTEM 280.00 mg Correction
6873 Q4 2021 POVIDONE K90 TOPICAL SYSTEM 280 mg Correction
6874 Q3 2021 POVIDONE K27 ORAL TABLET, EXTENDED RELEASE 10.00 mg Correction
6874 Q4 2021 POVIDONE K27 ORAL TABLET, EXTENDED RELEASE 10.00 mg Correction
6938 Q3 2021 PROPYLENE GLYCOL TOPICAL CLOTH 15.00 mg Correction
6938 Q4 2021 PROPYLENE GLYCOL TOPICAL CLOTH 0.02 mg/mg Correction
7188 Q3 2021 SCOTCHPAK 1022 TRANSDERMAL SYSTEM 364.46 mg Correction
7188 Q4 2021 SCOTCHPAK 9755 TRANSDERMAL SYSTEM 364.46 mg Correction
7445 Q3 2021 SODIUM BENZOATE ORAL TABLET, COATED 9.00 mg Correction
7445 Q4 2021 SODIUM BENZOATE ORAL TABLET, COATED 0.20 mg Correction
7827 Q3 2021 SODIUM HYDROXIDE ORAL CAPSULE, EXTENDED RELEASE 0.03 mg Correction
7827 Q4 2021 SODIUM HYDROXIDE ORAL CAPSULE, EXTENDED RELEASE 0.01 mg Correction
8063 Q3 2021 SODIUM PHOSPHATE, DIBASIC ORAL SUSPENSION 8.00 mg/ 1.00 ml Correction
8063 Q4 2021 SODIUM PHOSPHATE, DIBASIC ORAL SUSPENSION 4.50 mg/ 1.00 ml Correction
8084 Q3 2021 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS INTRATHECAL INJECTION, SOLUTION 0.01 %w/w Correction
8084 Q4 2021 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS INTRATHECAL INJECTION, SOLUTION 0.01 %w/v Correction
8376 Q3 2021 SODIUM SULFATE OPHTHALMIC SUSPENSION 1.20 %w/w Correction
8376 Q4 2021 SODIUM SULFATE OPHTHALMIC SUSPENSION 1.20 %w/v Correction
8528 Q3 2021 SORBITOL NASAL SPRAY 44.80 mg/ 1.00 ml Correction
8528 Q4 2021 SORBITOL NASAL SPRAY 6.17 mg/ 1.00 ml Correction
8541 Q3 2021 SORBITOL ORAL SOLUTION 18000 mg Correction
8541 Q4 2021 SORBITOL ORAL SOLUTION 12000 mg Correction
8643 Q3 2021 STARCH VAGINAL TABLET 305.00 mg Correction
8643 Q4 2021 STARCH VAGINAL TABLET 260.00 mg Correction
8961 Q3 2021 TALC ORAL TABLET, MULTILAYER, EXTENDED RELEASE 18 mg Correction
8961 Q4 2021 TALC ORAL TABLET, MULTILAYER, EXTENDED RELEASE 9.00 mg Correction
19 Q3 2021 .ALPHA.-TOCOPHEROL, DL- ORAL CAPSULE 1.00 mg MDE Replacement
19 Q4 2021 .ALPHA.-TOCOPHEROL, DL- ORAL CAPSULE 7 mg MDE Replacement
42 Q3 2021 ACACIA ORAL POWDER, FOR SUSPENSION 648.00 mg MDE Replacement
42 Q4 2021 ACACIA ORAL POWDER, FOR SUSPENSION 7386 mg MDE Replacement
57 Q3 2021 ACESULFAME ORAL SOLUTION 4.00 mg/ 1.00 ml MDE Replacement
57 Q4 2021 ACESULFAME ORAL SOLUTION 120 mg MDE Replacement
64 Q3 2021 ACESULFAME POTASSIUM ORAL SOLUTION 200.00 mg MDE Replacement
64 Q4 2021 ACESULFAME POTASSIUM ORAL SOLUTION 288 mg MDE Replacement
66 Q3 2021 ACESULFAME POTASSIUM ORAL TABLET 27.80 mg MDE Replacement
66 Q4 2021 ACESULFAME POTASSIUM ORAL TABLET 111.2 mg MDE Replacement
70 Q3 2021 ACESULFAME POTASSIUM ORAL TABLET, FOR SUSPENSION 1.80 mg MDE Replacement
70 Q4 2021 ACESULFAME POTASSIUM ORAL TABLET, FOR SUSPENSION 7.2 mg MDE Replacement
128 Q3 2021 ACRYL-EZE 93018509 WHITE ORAL TABLET 76.68 mg MDE Replacement
128 Q4 2021 ACRYL-EZE 93018509 WHITE ORAL TABLET 153.36 mg MDE Replacement
159 Q3 2021 ALCOHOL INTRAMUSCULAR INJECTION 20.00 %w/v MDE Replacement
159 Q4 2021 ALCOHOL INTRAMUSCULAR INJECTION 1000 mg MDE Replacement
164 Q3 2021 ALCOHOL INTRAVENOUS INJECTION, EMULSION 2.85 %w/v MDE Replacement
164 Q4 2021 ALCOHOL INTRAVENOUS INJECTION, EMULSION 520 mg MDE Replacement
183 Q3 2021 ALCOHOL ORAL SUSPENSION 72.50 mg MDE Replacement
183 Q4 2021 ALCOHOL ORAL SUSPENSION 520 mg MDE Replacement
185 Q3 2021 ALCOHOL ORAL SYRUP 81.30 mg/ 1.00 ml MDE Replacement
185 Q4 2021 ALCOHOL ORAL SYRUP 21000 mg MDE Replacement
193 Q3 2021 ALCOHOL SUBLINGUAL SPRAY 49.60 mg/ 1.00 ml MDE Replacement
193 Q4 2021 ALCOHOL SUBLINGUAL SPRAY 396.8 mg MDE Replacement
198 Q3 2021 ALCOHOL TOPICAL GEL, METERED 72.60 %w/w MDE Replacement
198 Q4 2021 ALCOHOL TOPICAL GEL, METERED 525 mg MDE Replacement
237 Q3 2021 ALUMINUM POLYESTER TRANSDERMAL FILM, EXTENDED RELEASE 81.00 mg MDE Replacement
237 Q4 2021 ALUMINUM POLYESTER TRANSDERMAL FILM, EXTENDED RELEASE 81 mg MDE Replacement
240 Q3 2021 ALUMINUM SILICATE ORAL TABLET, EXTENDED RELEASE 94.00 mg MDE Replacement
240 Q4 2021 ALUMINUM SILICATE ORAL TABLET, EXTENDED RELEASE 94 mg MDE Replacement
242 Q3 2021 ALUMINUM SILICATE TOPICAL SYSTEM 18.90 mg MDE Replacement
242 Q4 2021 ALUMINUM SILICATE TOPICAL SYSTEM 18.9 mg MDE Replacement
245 Q3 2021 ALUMINUM STEARATE ORAL CAPSULE, EXTENDED RELEASE 0.40 mg MDE Replacement
245 Q4 2021 ALUMINUM STEARATE ORAL CAPSULE, EXTENDED RELEASE 0.8 mg MDE Replacement
246 Q3 2021 ALUMINUM STEARATE ORAL TABLET 2.80 mg MDE Replacement
246 Q4 2021 ALUMINUM STEARATE ORAL TABLET 5.6 mg MDE Replacement
287 Q3 2021 AMMONIA SOLUTION ORAL TABLET, EXTENDED RELEASE NA MDE Replacement
287 Q4 2021 AMMONIA SOLUTION ORAL TABLET, EXTENDED RELEASE 5.9 mg MDE Replacement
296 Q3 2021 AMMONIO METHACRYLATE COPOLYMER TYPE A ORAL CAPSULE, EXTENDED RELEASE 42.40 mg MDE Replacement
296 Q4 2021 AMMONIO METHACRYLATE COPOLYMER TYPE A ORAL CAPSULE, EXTENDED RELEASE 63.6 mg MDE Replacement
300 Q3 2021 AMMONIO METHACRYLATE COPOLYMER TYPE B ORAL CAPSULE 109.56 mg MDE Replacement
300 Q4 2021 AMMONIO METHACRYLATE COPOLYMER TYPE B ORAL CAPSULE 219.12 mg MDE Replacement
301 Q3 2021 AMMONIO METHACRYLATE COPOLYMER TYPE B ORAL CAPSULE, EXTENDED RELEASE 91.88 mg MDE Replacement
301 Q4 2021 AMMONIO METHACRYLATE COPOLYMER TYPE B ORAL CAPSULE, EXTENDED RELEASE 178.34 mg MDE Replacement
305 Q3 2021 AMMONIO METHACRYLATE COPOLYMER TYPE B ORAL TABLET, FILM COATED 8.00 mg MDE Replacement
305 Q4 2021 AMMONIO METHACRYLATE COPOLYMER TYPE B ORAL TABLET, FILM COATED 32 mg MDE Replacement
311 Q3 2021 AMMONIUM CHLORIDE ORAL TABLET 4.20 mg MDE Replacement
311 Q4 2021 AMMONIUM CHLORIDE ORAL TABLET 8.4 mg MDE Replacement
328 Q3 2021 ANHYDROUS CITRIC ACID INTRACARDIAC INJECTION 0.25 %w/v MDE Replacement
328 Q4 2021 ANHYDROUS CITRIC ACID INTRACARDIAC INJECTION 22.5 mg MDE Replacement
329 Q3 2021 ANHYDROUS CITRIC ACID INTRAMUSCULAR INJECTION 0.33 %w/v MDE Replacement
329 Q4 2021 ANHYDROUS CITRIC ACID INTRAMUSCULAR INJECTION 22.5 mg MDE Replacement
332 Q3 2021 ANHYDROUS CITRIC ACID INTRAVENOUS INJECTION 166.00 mg MDE Replacement
332 Q4 2021 ANHYDROUS CITRIC ACID INTRAVENOUS INJECTION 510 mg MDE Replacement
346 Q3 2021 ANHYDROUS CITRIC ACID ORAL GRANULE, FOR SUSPENSION 4.90 mg MDE Replacement
346 Q4 2021 ANHYDROUS CITRIC ACID ORAL GRANULE, FOR SUSPENSION 29.4 mg MDE Replacement
359 Q3 2021 ANHYDROUS CITRIC ACID ORAL TABLET, CHEWABLE, EXTENDED RELEASE 8.00 mg MDE Replacement
359 Q4 2021 ANHYDROUS CITRIC ACID ORAL TABLET, CHEWABLE, EXTENDED RELEASE 12 mg MDE Replacement
366 Q3 2021 ANHYDROUS CITRIC ACID SUBCUTANEOUS INJECTION 0.25 %w/v MDE Replacement
366 Q4 2021 ANHYDROUS CITRIC ACID SUBCUTANEOUS INJECTION 22.5 mg MDE Replacement
385 Q3 2021 ANHYDROUS DEXTROSE INTRAVENOUS INJECTION 2000.00 mg MDE Replacement
385 Q4 2021 ANHYDROUS DEXTROSE INTRAVENOUS INJECTION 2700 mg MDE Replacement
388 Q3 2021 ANHYDROUS DEXTROSE NASAL SPRAY, METERED 50.00 mg MDE Replacement
388 Q4 2021 ANHYDROUS DEXTROSE NASAL SPRAY, METERED 200 mg MDE Replacement
389 Q3 2021 ANHYDROUS DEXTROSE ORAL GRANULE, FOR SUSPENSION 2813.00 mg MDE Replacement
389 Q4 2021 ANHYDROUS DEXTROSE ORAL GRANULE, FOR SUSPENSION 16878 mg MDE Replacement
391 Q3 2021 ANHYDROUS DEXTROSE ORAL TABLET, EXTENDED RELEASE 15.00 mg MDE Replacement
391 Q4 2021 ANHYDROUS DEXTROSE ORAL TABLET, EXTENDED RELEASE 30 mg MDE Replacement
396 Q3 2021 ANHYDROUS DIBASIC CALCIUM PHOSPHATE ORAL CAPSULE, DELAYED RELEASE 381.00 mg MDE Replacement
396 Q4 2021 ANHYDROUS DIBASIC CALCIUM PHOSPHATE ORAL CAPSULE, DELAYED RELEASE 381 mg MDE Replacement
406 Q3 2021 ANHYDROUS DIBASIC CALCIUM PHOSPHATE ORAL TABLET, FOR SUSPENSION 101.50 mg MDE Replacement
406 Q4 2021 ANHYDROUS DIBASIC CALCIUM PHOSPHATE ORAL TABLET, FOR SUSPENSION 406 mg MDE Replacement
407 Q3 2021 ANHYDROUS DIBASIC CALCIUM PHOSPHATE SUBLINGUAL POWDER 10.00 mg MDE Replacement
407 Q4 2021 ANHYDROUS DIBASIC CALCIUM PHOSPHATE SUBLINGUAL POWDER 30 mg MDE Replacement
427 Q3 2021 ANHYDROUS LACTOSE ORAL TABLET, FILM COATED 622.21 mg MDE Replacement
427 Q4 2021 ANHYDROUS LACTOSE ORAL TABLET, FILM COATED 622.21 mg MDE Replacement
504 Q3 2021 ASCORBIC ACID ORAL CAPSULE, EXTENDED RELEASE 0.40 mg MDE Replacement
504 Q4 2021 ASCORBIC ACID ORAL CAPSULE, EXTENDED RELEASE 0.8 mg MDE Replacement
506 Q3 2021 ASCORBIC ACID ORAL POWDER, FOR SOLUTION 200.00 mg MDE Replacement
506 Q4 2021 ASCORBIC ACID ORAL POWDER, FOR SOLUTION 560 mg MDE Replacement
540 Q3 2021 ASPARTAME ORAL TABLET, CHEWABLE, EXTENDED RELEASE 12.00 mg MDE Replacement
540 Q4 2021 ASPARTAME ORAL TABLET, CHEWABLE, EXTENDED RELEASE 18 mg MDE Replacement
542 Q3 2021 ASPARTAME ORAL TABLET, FOR SUSPENSION 3.70 mg MDE Replacement
542 Q4 2021 ASPARTAME ORAL TABLET, FOR SUSPENSION 14.8 mg MDE Replacement
566 Q3 2021 BENZALKONIUM CHLORIDE INTRA-ARTICULAR INJECTION 0.02 %w/v MDE Replacement
566 Q4 2021 BENZALKONIUM CHLORIDE INTRA-ARTICULAR INJECTION 0.8 mg MDE Replacement
567 Q3 2021 BENZALKONIUM CHLORIDE INTRALESIONAL INJECTION 0.02 %w/v MDE Replacement
567 Q4 2021 BENZALKONIUM CHLORIDE INTRALESIONAL INJECTION 0.8 mg MDE Replacement
568 Q3 2021 BENZALKONIUM CHLORIDE INTRAMUSCULAR INJECTION 0.02 %w/v MDE Replacement
568 Q4 2021 BENZALKONIUM CHLORIDE INTRAMUSCULAR INJECTION 0.8 mg MDE Replacement
572 Q3 2021 BENZALKONIUM CHLORIDE NASAL SPRAY, METERED 0.70 mg/ 1.00 ml MDE Replacement
572 Q4 2021 BENZALKONIUM CHLORIDE NASAL SPRAY, METERED 0.8 mg MDE Replacement
609 Q3 2021 BENZOIC ACID ORAL SOLUTION 2.07 mg/ 1.00 ml MDE Replacement
609 Q4 2021 BENZOIC ACID ORAL SOLUTION 5.72 mg MDE Replacement
647 Q3 2021 BENZYL ALCOHOL INTRAVENOUS INJECTION 10.30 %w/v MDE Replacement
647 Q4 2021 BENZYL ALCOHOL INTRAVENOUS INJECTION 1620 mg MDE Replacement
670 Q3 2021 BENZYL ALCOHOL TOPICAL CREAM 2.70 %w/w MDE Replacement
670 Q4 2021 BENZYL ALCOHOL TOPICAL CREAM 30 mg MDE Replacement
707 Q3 2021 BLACK INK ORAL TABLET, EXTENDED RELEASE 1.00 mg MDE Replacement
707 Q4 2021 BLACK INK ORAL TABLET, EXTENDED RELEASE 3 mg MDE Replacement
801 Q3 2021 BUTYLATED HYDROXYTOLUENE TOPICAL GEL, METERED 0.10 %w/w MDE Replacement
801 Q4 2021 BUTYLATED HYDROXYTOLUENE TOPICAL GEL, METERED 3.5 mg MDE Replacement
820 Q3 2021 BUTYLPARABEN ORAL SUSPENSION 8.00 mg/ 5.00 ml MDE Replacement
820 Q4 2021 BUTYLPARABEN ORAL SUSPENSION 12 mg MDE Replacement
969 Q3 2021 CARBOMER COPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) TOPICAL GEL, METERED 0.90 %w/w MDE Replacement
969 Q4 2021 CARBOMER COPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) TOPICAL GEL, METERED 31.5 mg MDE Replacement
979 Q3 2021 CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) TOPICAL GEL 0.85 %w/w MDE Replacement
979 Q4 2021 CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) TOPICAL GEL 8.4 mg MDE Replacement
984 Q3 2021 CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) ORAL CAPSULE 20.00 mg MDE Replacement
984 Q4 2021 CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) ORAL CAPSULE 40 mg MDE Replacement
985 Q3 2021 CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) ORAL GRANULE, FOR SUSPENSION 150.00 mg/ 5.00 ml MDE Replacement
985 Q4 2021 CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) ORAL GRANULE, FOR SUSPENSION 600 mg MDE Replacement
1000 Q3 2021 CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) ORAL SUSPENSION 50.00 mg/ 5.00 ml MDE Replacement
1000 Q4 2021 CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) ORAL SUSPENSION 288 mg MDE Replacement
1001 Q3 2021 CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) ORAL TABLET, EXTENDED RELEASE 90.00 mg MDE Replacement
1001 Q4 2021 CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) ORAL TABLET, EXTENDED RELEASE 90 mg MDE Replacement
1002 Q3 2021 CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) ORAL TABLET, FILM COATED, EXTENDED RELEASE 3.00 mg MDE Replacement
1002 Q4 2021 CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) ORAL TABLET, FILM COATED, EXTENDED RELEASE 9 mg MDE Replacement
1003 Q3 2021 CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) ORAL TABLET, ORALLY DISINTEGRATING 0.30 mg MDE Replacement
1003 Q4 2021 CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) ORAL TABLET, ORALLY DISINTEGRATING 1.2 mg MDE Replacement
1016 Q3 2021 CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) TOPICAL CREAM, AUGMENTED 1.00 %w/w MDE Replacement
1016 Q4 2021 CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) TOPICAL CREAM, AUGMENTED 20 mg MDE Replacement
1017 Q3 2021 CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) TOPICAL EMULSION 0.60 %w/w MDE Replacement
1017 Q4 2021 CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) TOPICAL EMULSION 6 mg MDE Replacement
1019 Q3 2021 CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) TOPICAL LOTION 0.50 %w/w MDE Replacement
1019 Q4 2021 CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) TOPICAL LOTION 20 mg MDE Replacement
1020 Q3 2021 CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) TOPICAL OINTMENT, AUGMENTED 2.25 %w/w MDE Replacement
1020 Q4 2021 CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) TOPICAL OINTMENT, AUGMENTED 22.5 mg MDE Replacement
1039 Q3 2021 CARBOXYMETHYLCELLULOSE SODIUM BUCCAL FILM 17.64 mg MDE Replacement
1039 Q4 2021 CARBOXYMETHYLCELLULOSE SODIUM BUCCAL FILM 17.64 mg MDE Replacement
1041 Q3 2021 CARBOXYMETHYLCELLULOSE SODIUM BUCCAL FILM, SOLUBLE 10.95 mg MDE Replacement
1041 Q4 2021 CARBOXYMETHYLCELLULOSE SODIUM BUCCAL FILM, SOLUBLE 44 mg MDE Replacement
1067 Q3 2021 CARBOXYMETHYLCELLULOSE SODIUM ORAL SOLUTION 35.00 mg/ 1.00 ml MDE Replacement
1067 Q4 2021 CARBOXYMETHYLCELLULOSE SODIUM ORAL SOLUTION 1080 mg MDE Replacement
1125 Q3 2021 CASTOR OIL ORAL CAPSULE, EXTENDED RELEASE 1.76 mg MDE Replacement
1125 Q4 2021 CASTOR OIL ORAL CAPSULE, EXTENDED RELEASE 22 mg MDE Replacement
1127 Q3 2021 CASTOR OIL ORAL TABLET 2.00 mg MDE Replacement
1127 Q4 2021 CASTOR OIL ORAL TABLET 16.8175 mg MDE Replacement
1154 Q3 2021 CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM NASAL SPRAY, METERED 20.00 mg MDE Replacement
1154 Q4 2021 CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM NASAL SPRAY, METERED 60 mg MDE Replacement
1169 Q3 2021 CERESIN VAGINAL CREAM 7.00 %w/w MDE Replacement
1169 Q4 2021 CERESIN VAGINAL CREAM 280 mg MDE Replacement
Q3 2021 CROSCARMELLOSE SODIUM ORAL TABLET, FILM COATED 165.00 mg MDE Replacement
Q4 2021 CROSCARMELLOSE SODIUM ORAL TABLET, FILM COATED 330 mg MDE Replacement
1523 Q3 2021 CROSCARMELLOSE SODIUM ORAL TABLET, FOR SUSPENSION 30.00 mg MDE Replacement
1523 Q4 2021 CROSCARMELLOSE SODIUM ORAL TABLET, FOR SUSPENSION 46.4 mg MDE Replacement
1541 Q3 2021 CROSPOVIDONE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 60.00 mg MDE Replacement
1541 Q4 2021 CROSPOVIDONE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 90 mg MDE Replacement
1616 Q3 2021 D&C RED NO. 27 ALUMINUM LAKE ORAL TABLET 0.69 mg MDE Replacement
1616 Q4 2021 D&C RED NO. 27 ALUMINUM LAKE ORAL TABLET 1.2 mg MDE Replacement
1641 Q3 2021 D&C RED NO. 30 ORAL TABLET, CHEWABLE, EXTENDED RELEASE 0.30 mg MDE Replacement
1641 Q4 2021 D&C RED NO. 30 ORAL TABLET, CHEWABLE, EXTENDED RELEASE 0.6 mg MDE Replacement
1653 Q3 2021 D&C RED NO. 30 ALUMINUM LAKE ORAL TABLET, COATED 0.34 mg MDE Replacement
1653 Q4 2021 D&C RED NO. 30 ALUMINUM LAKE ORAL TABLET, COATED 4.96 mg MDE Replacement
1731 Q3 2021 D&C YELLOW NO. 10 ALUMINUM LAKE BUCCAL GUM, CHEWING 2.40 mg MDE Replacement
1731 Q4 2021 D&C YELLOW NO. 10 ALUMINUM LAKE BUCCAL GUM, CHEWING 40.4 mg MDE Replacement
1744 Q3 2021 D&C YELLOW NO. 10 ALUMINUM LAKE ORAL TABLET, EXTENDED RELEASE 2.82 mg MDE Replacement
1744 Q4 2021 D&C YELLOW NO. 10 ALUMINUM LAKE ORAL TABLET, EXTENDED RELEASE 4 mg MDE Replacement
1850 Q3 2021 DIBASIC CALCIUM PHOSPHATE DIHYDRATE ORAL TABLET, FILM COATED 635.50 mg MDE Replacement
1850 Q4 2021 DIBASIC CALCIUM PHOSPHATE DIHYDRATE ORAL TABLET, FILM COATED 953.28 mg MDE Replacement
1861 Q3 2021 DIBUTYL SEBACATE ORAL CAPSULE 15.47 mg MDE Replacement
1861 Q4 2021 DIBUTYL SEBACATE ORAL CAPSULE 30.94 mg MDE Replacement
1867 Q3 2021 DIBUTYL SEBACATE ORAL TABLET 6.00 mg MDE Replacement
1867 Q4 2021 DIBUTYL SEBACATE ORAL TABLET 22.75 mg MDE Replacement
1889 Q3 2021 DIETHYL PHTHALATE ORAL CAPSULE 9.57 mg MDE Replacement
1889 Q4 2021 DIETHYL PHTHALATE ORAL CAPSULE 19.14 mg MDE Replacement
1927 Q3 2021 DIMETHICONE 350 TOPICAL CREAM 1.00 %w/w MDE Replacement
1927 Q4 2021 DIMETHICONE 350 TOPICAL CREAM 114 mg MDE Replacement
2010 Q3 2021 DYE BROWN LAKE BLEND BUCCAL GUM, CHEWING 0.17 mg MDE Replacement
2010 Q4 2021 DYE BROWN LAKE BLEND BUCCAL GUM, CHEWING 3.4 mg MDE Replacement
2088 Q3 2021 EDETATE DISODIUM INTRACARDIAC INJECTION 0.02 %w/v MDE Replacement
2088 Q4 2021 EDETATE DISODIUM INTRACARDIAC INJECTION 1.8 mg MDE Replacement
2146 Q3 2021 EDETATE DISODIUM TOPICAL GEL 0.17 %w/w MDE Replacement
2146 Q4 2021 EDETATE DISODIUM TOPICAL GEL 1 mg MDE Replacement
2156 Q3 2021 EDETATE DISODIUM VAGINAL CREAM 0.05 %w/w MDE Replacement
2156 Q4 2021 EDETATE DISODIUM VAGINAL CREAM 2 mg MDE Replacement
2192 Q3 2021 EGG PHOSPHOLIPIDS INTRAVENOUS INJECTION, EMULSION 14.46 %w/v MDE Replacement
2192 Q4 2021 EGG PHOSPHOLIPIDS INTRAVENOUS INJECTION, EMULSION 2610 mg MDE Replacement
2261 Q3 2021 ETHYLCELLULOSE (10 MPA.S) ORAL CAPSULE, DELAYED RELEASE 11.79 mg MDE Replacement
2261 Q4 2021 ETHYLCELLULOSE (10 MPA.S) ORAL CAPSULE, DELAYED RELEASE 11.79 mg MDE Replacement
2262 Q3 2021 ETHYLCELLULOSE (10 MPA.S) ORAL CAPSULE, EXTENDED RELEASE 175.40 mg MDE Replacement
2262 Q4 2021 ETHYLCELLULOSE (10 MPA.S) ORAL CAPSULE, EXTENDED RELEASE 270 mg MDE Replacement
2286 Q3 2021 ETHYLCELLULOSE (50 MPA.S) ORAL CAPSULE 69.97 mg MDE Replacement
2286 Q4 2021 ETHYLCELLULOSE (50 MPA.S) ORAL CAPSULE 139.94 mg MDE Replacement
2400 Q3 2021 FD&C BLUE NO. 1 ALUMINUM LAKE ORAL TABLET 2.00 mg MDE Replacement
2400 Q4 2021 FD&C BLUE NO. 1 ALUMINUM LAKE ORAL TABLET 6 mg MDE Replacement
2478 Q3 2021 FD&C RED NO. 30--ALUMINUM LAKE ORAL TABLET 0.40 mg MDE Replacement
2478 Q4 2021 FD&C RED NO. 30--ALUMINUM LAKE ORAL TABLET 1.92 mg MDE Replacement
2610 Q3 2021 FERRIC OXIDE BROWN ORAL CAPSULE 1.12 mg MDE Replacement
2610 Q4 2021 FERRIC OXIDE BROWN ORAL CAPSULE 7.84 mg MDE Replacement
2630 Q3 2021 FERRIC OXIDE RED ORAL TABLET, FILM COATED 3.00 mg MDE Replacement
2630 Q4 2021 FERRIC OXIDE RED ORAL TABLET, FILM COATED 3.07 mg MDE Replacement
2644 Q3 2021 FERRIC OXIDE YELLOW ORAL CAPSULE, EXTENDED RELEASE 3.04 mg MDE Replacement
2644 Q4 2021 FERRIC OXIDE YELLOW ORAL CAPSULE, EXTENDED RELEASE 6.84 mg MDE Replacement
2646 Q3 2021 FERRIC OXIDE YELLOW ORAL GRANULE, FOR SUSPENSION 1.80 mg MDE Replacement
2646 Q4 2021 FERRIC OXIDE YELLOW ORAL GRANULE, FOR SUSPENSION 10.8 mg MDE Replacement
2688 Q3 2021 FLAVOR BANANA FN-6713 ORAL SOLUTION 20.00 mg/ 5.00 ml MDE Replacement
2688 Q4 2021 FLAVOR BANANA FN-6713 ORAL SOLUTION 117.12 mg MDE Replacement
2689 Q3 2021 FLAVOR BANANA GIVAUDAN 85509 ORAL SOLUTION 1.03 mg/ 1.00 ml MDE Replacement
2689 Q4 2021 FLAVOR BANANA GIVAUDAN 85509 ORAL SOLUTION 30.93 mg MDE Replacement
2756 Q3 2021 FLAVOR CITRUS/FRUIT FREEZE 1100609500 BUCCAL GUM, CHEWING 2.25 mg MDE Replacement
2756 Q4 2021 FLAVOR CITRUS/FRUIT FREEZE 1100609500 BUCCAL GUM, CHEWING 45 mg MDE Replacement
2772 Q3 2021 FLAVOR FRUIT FN-6714 ORAL SOLUTION 2.50 mg/ 5.00 ml MDE Replacement
2772 Q4 2021 FLAVOR FRUIT FN-6714 ORAL SOLUTION 36 mg MDE Replacement
2790 Q3 2021 FLAVOR GRAPE PFC-9924 ORAL SOLUTION 4.10 mg/ 1.00 ml MDE Replacement
2790 Q4 2021 FLAVOR GRAPE PFC-9924 ORAL SOLUTION 15 mg MDE Replacement
2808 Q3 2021 FLAVOR MENTHOL VERALOCK BUCCAL GUM, CHEWING 3.84 mg MDE Replacement
2808 Q4 2021 FLAVOR MENTHOL VERALOCK BUCCAL GUM, CHEWING 76.8 mg MDE Replacement
2809 Q3 2021 FLAVOR MINT 287 BUCCAL GUM, CHEWING 28.00 mg MDE Replacement
2809 Q4 2021 FLAVOR MINT 287 BUCCAL GUM, CHEWING 560 mg MDE Replacement
2849 Q3 2021 FLAVOR PEPPERMINT EXTRACT FN-2356 ORAL SOLUTION 5.00 mg/ 1.00 ml MDE Replacement
2849 Q4 2021 FLAVOR PEPPERMINT EXTRACT FN-2356 ORAL SOLUTION 288 mg MDE Replacement
3082 Q3 2021 GLYCERIN ORAL SUSPENSION 23520.00 mg MDE Replacement
3082 Q4 2021 GLYCERIN ORAL SUSPENSION 26208 mg MDE Replacement
3128 Q3 2021 GLYCERYL DIBEHENATE ORAL POWDER, FOR SOLUTION 2.00 mg MDE Replacement
3128 Q4 2021 GLYCERYL DIBEHENATE ORAL POWDER, FOR SOLUTION 2 mg MDE Replacement
3158 Q3 2021 GLYCERYL MONO AND DIPALMITOSTEARATE VAGINAL CREAM 4.00 %w/w MDE Replacement
3158 Q4 2021 GLYCERYL MONO AND DIPALMITOSTEARATE VAGINAL CREAM 160 mg MDE Replacement
3162 Q3 2021 GLYCERYL MONOCAPRYLOCAPRATE ORAL CAPSULE 374.24 mg MDE Replacement
3162 Q4 2021 GLYCERYL MONOCAPRYLOCAPRATE ORAL CAPSULE 501.9 mg MDE Replacement
3256 Q3 2021 GUAR GUM ORAL TABLET, CHEWABLE, EXTENDED RELEASE 24.00 mg MDE Replacement
3256 Q4 2021 GUAR GUM ORAL TABLET, CHEWABLE, EXTENDED RELEASE 36 mg MDE Replacement
3478 Q3 2021 HYDROGENATED COTTONSEED OIL ORAL TABLET 34.00 mg MDE Replacement
3478 Q4 2021 HYDROGENATED COTTONSEED OIL ORAL TABLET 54.4 mg MDE Replacement
3482 Q3 2021 HYDROGENATED COTTONSEED OIL ORAL TABLET, EXTENDED RELEASE 228.00 mg MDE Replacement
3482 Q4 2021 HYDROGENATED COTTONSEED OIL ORAL TABLET, EXTENDED RELEASE 2280 mg MDE Replacement
3493 Q3 2021 HYDROGENATED SOYBEAN OIL ORAL TABLET, EXTENDED RELEASE 48.00 mg MDE Replacement
3493 Q4 2021 HYDROGENATED SOYBEAN OIL ORAL TABLET, EXTENDED RELEASE 96 mg MDE Replacement
3508 Q3 2021 HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) BUCCAL FILM 54.92 mg MDE Replacement
3508 Q4 2021 HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) BUCCAL FILM 54.92 mg MDE Replacement
3509 Q3 2021 HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) BUCCAL FILM, SOLUBLE 39.88 mg MDE Replacement
3509 Q4 2021 HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) BUCCAL FILM, SOLUBLE 160 mg MDE Replacement
3542 Q3 2021 HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%) ORAL TABLET, EXTENDED RELEASE 400.00 mg MDE Replacement
3542 Q4 2021 HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%) ORAL TABLET, EXTENDED RELEASE 800 mg MDE Replacement
3544 Q3 2021 HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%) TOPICAL GEL 1.50 %w/w MDE Replacement
3544 Q4 2021 HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%) TOPICAL GEL 25 mg MDE Replacement
3550 Q3 2021 HYDROXYETHYL CELLULOSE (6500 MPA.S AT 2%) ORAL TABLET, EXTENDED RELEASE 150.00 mg MDE Replacement
3550 Q4 2021 HYDROXYETHYL CELLULOSE (6500 MPA.S AT 2%) ORAL TABLET, EXTENDED RELEASE 300 mg MDE Replacement
3584 Q3 2021 HYDROXYPROPYL CELLULOSE (1600000 WAMW) BUCCAL FILM, SOLUBLE 72.91 mg MDE Replacement
3584 Q4 2021 HYDROXYPROPYL CELLULOSE (1600000 WAMW) BUCCAL FILM, SOLUBLE 292 mg MDE Replacement
3591 Q3 2021 HYDROXYPROPYL CELLULOSE (1600000 WAMW) ORAL GRANULE, FOR SUSPENSION 39.00 mg MDE Replacement
3591 Q4 2021 HYDROXYPROPYL CELLULOSE (1600000 WAMW) ORAL GRANULE, FOR SUSPENSION 193.8 mg MDE Replacement
3639 Q3 2021 HYPROMELLOSE ORAL CAPSULE, DELAYED RELEASE 4.50 mg MDE Replacement
3639 Q4 2021 HYPROMELLOSE ORAL CAPSULE, DELAYED RELEASE 34.85 mg MDE Replacement
3660 Q3 2021 HYPROMELLOSE ORAL TABLET, COATED 35.39 mg MDE Replacement
3660 Q4 2021 HYPROMELLOSE ORAL TABLET, COATED 57.6 mg MDE Replacement
3682 Q3 2021 HYPROMELLOSE 2208 (100 MPA.S) ORAL SUSPENSION 50.00 mg/ 5.00 ml MDE Replacement
3682 Q4 2021 HYPROMELLOSE 2208 (100 MPA.S) ORAL SUSPENSION 50 mg MDE Replacement
3683 Q3 2021 HYPROMELLOSE 2208 (100 MPA.S) ORAL SYRUP 12.50 mg/ 5.00 ml MDE Replacement
3683 Q4 2021 HYPROMELLOSE 2208 (100 MPA.S) ORAL SYRUP 100 mg MDE Replacement
3685 Q3 2021 HYPROMELLOSE 2208 (100 MPA.S) ORAL TABLET, DELAYED RELEASE 90.00 mg MDE Replacement
3685 Q4 2021 HYPROMELLOSE 2208 (100 MPA.S) ORAL TABLET, DELAYED RELEASE 360 mg MDE Replacement
3700 Q3 2021 HYPROMELLOSE 2208 (15000 MPA.S) ORAL TABLET, FILM COATED, EXTENDED RELEASE 300.00 mg MDE Replacement
3700 Q4 2021 HYPROMELLOSE 2208 (15000 MPA.S) ORAL TABLET, FILM COATED, EXTENDED RELEASE 400 mg MDE Replacement
3701 Q3 2021 HYPROMELLOSE 2208 (200000 MPA.S) ORAL TABLET, EXTENDED RELEASE 212.00 mg MDE Replacement
3701 Q4 2021 HYPROMELLOSE 2208 (200000 MPA.S) ORAL TABLET, EXTENDED RELEASE 460 mg MDE Replacement
3720 Q3 2021 HYPROMELLOSE 2208 (4000 MPA.S) VAGINAL CREAM 0.30 %w/w MDE Replacement
3720 Q4 2021 HYPROMELLOSE 2208 (4000 MPA.S) VAGINAL CREAM 12 mg MDE Replacement
3739 Q3 2021 HYPROMELLOSE 2910 (15 MPA.S) ORAL CAPSULE, EXTENDED RELEASE 54.40 mg MDE Replacement
3739 Q4 2021 HYPROMELLOSE 2910 (15 MPA.S) ORAL CAPSULE, EXTENDED RELEASE 70.7 mg MDE Replacement
3744 Q3 2021 HYPROMELLOSE 2910 (15 MPA.S) ORAL TABLET, EXTENDED RELEASE 255.85 mg MDE Replacement
3744 Q4 2021 HYPROMELLOSE 2910 (15 MPA.S) ORAL TABLET, EXTENDED RELEASE 510 mg MDE Replacement
3746 Q3 2021 HYPROMELLOSE 2910 (15 MPA.S) ORAL TABLET, FILM COATED, EXTENDED RELEASE 7.50 mg MDE Replacement
3746 Q4 2021 HYPROMELLOSE 2910 (15 MPA.S) ORAL TABLET, FILM COATED, EXTENDED RELEASE 15 mg MDE Replacement
3754 Q3 2021 HYPROMELLOSE 2910 (3 MPA.S) ORAL CAPSULE 193.91 mg MDE Replacement
3754 Q4 2021 HYPROMELLOSE 2910 (3 MPA.S) ORAL CAPSULE 775.64 mg MDE Replacement
3755 Q3 2021 HYPROMELLOSE 2910 (3 MPA.S) ORAL GRANULE 10.40 mg MDE Replacement
3755 Q4 2021 HYPROMELLOSE 2910 (3 MPA.S) ORAL GRANULE 21 mg MDE Replacement
3756 Q3 2021 HYPROMELLOSE 2910 (3 MPA.S) ORAL GRANULE, FOR SUSPENSION 1.00 mg MDE Replacement
3756 Q4 2021 HYPROMELLOSE 2910 (3 MPA.S) ORAL GRANULE, FOR SUSPENSION 1 mg MDE Replacement
3761 Q3 2021 HYPROMELLOSE 2910 (3 MPA.S) ORAL TABLET, EXTENDED RELEASE 42.41 mg MDE Replacement
3761 Q4 2021 HYPROMELLOSE 2910 (3 MPA.S) ORAL TABLET, EXTENDED RELEASE 53.32 mg MDE Replacement
3768 Q3 2021 HYPROMELLOSE 2910 (4000 MPA.S) NASAL SPRAY, METERED 1.00 mg/ 1.00 ml MDE Replacement
3768 Q4 2021 HYPROMELLOSE 2910 (4000 MPA.S) NASAL SPRAY, METERED 1.096 mg MDE Replacement
3778 Q3 2021 HYPROMELLOSE 2910 (4000 MPA.S) ORAL SYRUP 180.00 mg/ 5.00 ml MDE Replacement
3778 Q4 2021 HYPROMELLOSE 2910 (4000 MPA.S) ORAL SYRUP 360 mg MDE Replacement
3794 Q3 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL CAPSULE, EXTENDED RELEASE 670.04 mg MDE Replacement
3794 Q4 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL CAPSULE, EXTENDED RELEASE 963.81 mg MDE Replacement
3796 Q3 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL GRANULE, FOR SUSPENSION 24.08 mg MDE Replacement
3796 Q4 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL GRANULE, FOR SUSPENSION 48.16 mg MDE Replacement
3797 Q3 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL POWDER, FOR SUSPENSION 75.00 mg/ 5.00 ml MDE Replacement
3797 Q4 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL POWDER, FOR SUSPENSION 450 mg MDE Replacement
3798 Q3 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL SUSPENSION 325.00 mg/ 5.00 ml MDE Replacement
3798 Q4 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL SUSPENSION 975 mg MDE Replacement
3800 Q3 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL SYRUP 5.00 mg/ 1.00 ml MDE Replacement
3800 Q4 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL SYRUP 200 mg MDE Replacement
3801 Q3 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL TABLET 444.40 mg MDE Replacement
3801 Q4 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL TABLET 1200 mg MDE Replacement
3807 Q3 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL TABLET, FILM COATED, EXTENDED RELEASE 54.00 mg MDE Replacement
3807 Q4 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL TABLET, FILM COATED, EXTENDED RELEASE 106.6 mg MDE Replacement
3808 Q3 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL TABLET, FOR SUSPENSION 19.00 mg MDE Replacement
3808 Q4 2021 HYPROMELLOSE 2910 (5 MPA.S) ORAL TABLET, FOR SUSPENSION 76 mg MDE Replacement
Q3 2021 HYPROMELLOSE 2910 (6 MPA.S) ORAL CAPSULE, DELAYED RELEASE 78.00 mg MDE Replacement
Q4 2021 HYPROMELLOSE 2910 (6 MPA.S) ORAL CAPSULE, DELAYED RELEASE 223 mg MDE Replacement
3832 Q3 2021 HYPROMELLOSE ACETATE SUCCINATE ORAL CAPSULE, EXTENDED RELEASE 66.78 mg MDE Replacement
3832 Q4 2021 HYPROMELLOSE ACETATE SUCCINATE ORAL CAPSULE, EXTENDED RELEASE 66.78 mg MDE Replacement
3891 Q3 2021 INK BLACK SW-9008 ORAL CAPSULE, EXTENDED RELEASE 0.28 mg MDE Replacement
3891 Q4 2021 INK BLACK SW-9008 ORAL CAPSULE, EXTENDED RELEASE 0.675 mg MDE Replacement
3941 Q3 2021 ISOMALT SUBLINGUAL POWDER 176.80 mg MDE Replacement
3941 Q4 2021 ISOMALT SUBLINGUAL POWDER 530.4 mg MDE Replacement
3972 Q3 2021 ISOPROPYL PALMITATE TOPICAL CREAM 5.00 %w/w MDE Replacement
3972 Q4 2021 ISOPROPYL PALMITATE TOPICAL CREAM 32.15 mg MDE Replacement
4114 Q3 2021 LACTOSE MONOHYDRATE ORAL TABLET, FILM COATED, EXTENDED RELEASE 260.00 mg MDE Replacement
4114 Q4 2021 LACTOSE MONOHYDRATE ORAL TABLET, FILM COATED, EXTENDED RELEASE 520 mg MDE Replacement
4240 Q3 2021 LIGHT MINERAL OIL TOPICAL CREAM 20.00 %w/w MDE Replacement
4240 Q4 2021 LIGHT MINERAL OIL TOPICAL CREAM 456 mg MDE Replacement
4270 Q3 2021 LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 120000 MW) ORAL TABLET 80.00 mg MDE Replacement
4270 Q4 2021 LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 120000 MW) ORAL TABLET 369.6 mg MDE Replacement
4272 Q3 2021 LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 120000 MW) ORAL TABLET, DELAYED RELEASE 26.30 mg MDE Replacement
4272 Q4 2021 LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 120000 MW) ORAL TABLET, DELAYED RELEASE 84 mg MDE Replacement
4344 Q3 2021 MAGNESIUM OXIDE BUCCAL GUM, CHEWING 7.20 mg MDE Replacement
4344 Q4 2021 MAGNESIUM OXIDE BUCCAL GUM, CHEWING 144 mg MDE Replacement
4386 Q3 2021 MAGNESIUM STEARATE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 6.00 mg MDE Replacement
4386 Q4 2021 MAGNESIUM STEARATE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 9 mg MDE Replacement
4390 Q3 2021 MAGNESIUM STEARATE ORAL TABLET, EXTENDED RELEASE 150.00 mg MDE Replacement
4390 Q4 2021 MAGNESIUM STEARATE ORAL TABLET, EXTENDED RELEASE 160 mg MDE Replacement
4452 Q3 2021 MALTODEXTRIN ORAL SOLUTION 145.10 mg MDE Replacement
4452 Q4 2021 MALTODEXTRIN ORAL SOLUTION 1451 mg MDE Replacement
4476 Q3 2021 MANNITOL INTRAVENOUS INJECTION 1000.00 mg MDE Replacement
4476 Q4 2021 MANNITOL INTRAVENOUS INJECTION 15200 mg MDE Replacement
4495 Q3 2021 MANNITOL ORAL CAPSULE, EXTENDED RELEASE 53.40 mg MDE Replacement
4495 Q4 2021 MANNITOL ORAL CAPSULE, EXTENDED RELEASE 160.2 mg MDE Replacement
4500 Q3 2021 MANNITOL ORAL POWDER, FOR SOLUTION 1345.50 mg MDE Replacement
4500 Q4 2021 MANNITOL ORAL POWDER, FOR SOLUTION 3767.4 mg MDE Replacement
4507 Q3 2021 MANNITOL ORAL TABLET, CHEWABLE, EXTENDED RELEASE 410.60 mg MDE Replacement
4507 Q4 2021 MANNITOL ORAL TABLET, CHEWABLE, EXTENDED RELEASE 615.9 mg MDE Replacement
4510 Q3 2021 MANNITOL ORAL TABLET, EXTENDED RELEASE 392.20 mg MDE Replacement
4510 Q4 2021 MANNITOL ORAL TABLET, EXTENDED RELEASE 434 mg MDE Replacement
4548 Q3 2021 MEDIUM-CHAIN TRIGLYCERIDES SUBLINGUAL POWDER 0.80 mg MDE Replacement
4548 Q4 2021 MEDIUM-CHAIN TRIGLYCERIDES SUBLINGUAL POWDER 2.4 mg MDE Replacement
4551 Q3 2021 MEDIUM-CHAIN TRIGLYCERIDES TOPICAL CREAM 15.00 %w/w MDE Replacement
4551 Q4 2021 MEDIUM-CHAIN TRIGLYCERIDES TOPICAL CREAM 570 mg MDE Replacement
4611 Q3 2021 METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A ORAL GRANULE, FOR SUSPENSION 38.00 mg MDE Replacement
4611 Q4 2021 METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A ORAL GRANULE, FOR SUSPENSION 82.2 mg MDE Replacement
4647 Q3 2021 METHACRYLIC ACID COPOLYMER ORAL TABLET, EXTENDED RELEASE 61.91 mg MDE Replacement
4647 Q4 2021 METHACRYLIC ACID COPOLYMER ORAL TABLET, EXTENDED RELEASE 99.3 mg MDE Replacement
4697 Q3 2021 METHYLCELLULOSE ORAL TABLET 183.60 mg MDE Replacement
4697 Q4 2021 METHYLCELLULOSE ORAL TABLET 816 mg MDE Replacement
4716 Q3 2021 METHYLCELLULOSE (1500 MPA.S) ORAL TABLET 2.75 mg MDE Replacement
4716 Q4 2021 METHYLCELLULOSE (1500 MPA.S) ORAL TABLET 319.2 mg MDE Replacement
4725 Q3 2021 METHYLPARABEN BUCCAL FILM 1.00 mg MDE Replacement
4725 Q4 2021 METHYLPARABEN BUCCAL FILM 1 mg MDE Replacement
4726 Q3 2021 METHYLPARABEN BUCCAL FILM, SOLUBLE 0.71 mg MDE Replacement
4726 Q4 2021 METHYLPARABEN BUCCAL FILM, SOLUBLE 3 mg MDE Replacement
4802 Q3 2021 METHYLPARABEN VAGINAL CREAM 0.20 %w/w MDE Replacement
4802 Q4 2021 METHYLPARABEN VAGINAL CREAM 6 mg MDE Replacement
4832 Q3 2021 MICROCRYSTALLINE CELLULOSE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 96.00 mg MDE Replacement
4832 Q4 2021 MICROCRYSTALLINE CELLULOSE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 144 mg MDE Replacement
4868 Q3 2021 MINERAL OIL TOPICAL CREAM 50.62 %w/w MDE Replacement
4868 Q4 2021 MINERAL OIL TOPICAL CREAM 1518 mg MDE Replacement
4904 Q3 2021 MONOBASIC POTASSIUM PHOSPHATE INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 68.00 mg MDE Replacement
4904 Q4 2021 MONOBASIC POTASSIUM PHOSPHATE INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 110.16 mg MDE Replacement
4949 Q3 2021 N,N-DIMETHYLACETAMIDE INTRAVENOUS INJECTION 30.89 %w/v MDE Replacement
4949 Q4 2021 N,N-DIMETHYLACETAMIDE INTRAVENOUS INJECTION 12320 mg MDE Replacement
5003 Q3 2021 OLEIC ACID ORAL TABLET, EXTENDED RELEASE 2.00 mg MDE Replacement
5003 Q4 2021 OLEIC ACID ORAL TABLET, EXTENDED RELEASE 2.95 mg MDE Replacement
5007 Q3 2021 OLEIC ACID TOPICAL GEL, METERED 2.50 %w/w MDE Replacement
5007 Q4 2021 OLEIC ACID TOPICAL GEL, METERED 87.5 mg MDE Replacement
5127 Q3 2021 OPADRY 03B58902 WHITE ORAL TABLET 10.50 mg MDE Replacement
5127 Q4 2021 OPADRY 03B58902 WHITE ORAL TABLET 21 mg MDE Replacement
5136 Q3 2021 OPADRY 03F14895 PINK ORAL TABLET, FILM COATED 4.00 mg MDE Replacement
5136 Q4 2021 OPADRY 03F14895 PINK ORAL TABLET, FILM COATED 8 mg MDE Replacement
5139 Q3 2021 OPADRY 03F59016 CLEAR ORAL TABLET, EXTENDED RELEASE 4.00 mg MDE Replacement
5139 Q4 2021 OPADRY 03F59016 CLEAR ORAL TABLET, EXTENDED RELEASE 8 mg MDE Replacement
5185 Q3 2021 OPADRY AMB 80W68912 WHITE ORAL TABLET, EXTENDED RELEASE 36.00 mg MDE Replacement
5185 Q4 2021 OPADRY AMB 80W68912 WHITE ORAL TABLET, EXTENDED RELEASE 72 mg MDE Replacement
5186 Q3 2021 OPADRY AMB 80W68912 WHITE ORAL TABLET, FILM COATED 18.00 mg MDE Replacement
5186 Q4 2021 OPADRY AMB 80W68912 WHITE ORAL TABLET, FILM COATED 18 mg MDE Replacement
5207 Q3 2021 OPADRY II 33G28707 WHITE ORAL TABLET, EXTENDED RELEASE 30.00 mg MDE Replacement
5207 Q4 2021 OPADRY II 33G28707 WHITE ORAL TABLET, EXTENDED RELEASE 60 mg MDE Replacement
5221 Q3 2021 OPADRY II 49B10882 BLUE ORAL TABLET 26.90 mg MDE Replacement
5221 Q4 2021 OPADRY II 49B10882 BLUE ORAL TABLET 53.8 mg MDE Replacement
5236 Q3 2021 OPADRY II 85F18422 WHITE ORAL TABLET, EXTENDED RELEASE 51.30 mg MDE Replacement
5236 Q4 2021 OPADRY II 85F18422 WHITE ORAL TABLET, EXTENDED RELEASE 72 mg MDE Replacement
5345 Q3 2021 OPADRY OY-58900 WHITE ORAL TABLET 31.80 mg MDE Replacement
5345 Q4 2021 OPADRY OY-58900 WHITE ORAL TABLET 132 mg MDE Replacement
5346 Q3 2021 OPADRY OY-58900 WHITE ORAL TABLET, FILM COATED 16.25 mg MDE Replacement
5346 Q4 2021 OPADRY OY-58900 WHITE ORAL TABLET, FILM COATED 65 mg MDE Replacement
5410 Q3 2021 OPADRY Y-5-7068 WHITE ORAL TABLET 120.00 mg MDE Replacement
5410 Q4 2021 OPADRY Y-5-7068 WHITE ORAL TABLET 290.25 mg MDE Replacement
5559 Q3 2021 OPADRY YS-1-7003 WHITE ORAL TABLET 147.80 mg MDE Replacement
5559 Q4 2021 OPADRY YS-1-7003 WHITE ORAL TABLET 402.84 mg MDE Replacement
5571 Q3 2021 OPADRY YS-1-7006 CLEAR ORAL TABLET 56.05 mg MDE Replacement
5571 Q4 2021 OPADRY YS-1-7006 CLEAR ORAL TABLET 111.24 mg MDE Replacement
5590 Q3 2021 OPADRY YS-1-7472 CLEAR ORAL CAPSULE, EXTENDED RELEASE 50.76 mg MDE Replacement
5590 Q4 2021 OPADRY YS-1-7472 CLEAR ORAL CAPSULE, EXTENDED RELEASE 50.76 mg MDE Replacement
5611 Q3 2021 OPADRY YS-1R-7006 CLEAR ORAL TABLET 26.25 mg MDE Replacement
5611 Q4 2021 OPADRY YS-1R-7006 CLEAR ORAL TABLET 37.54 mg MDE Replacement
5860 Q3 2021 PEPPERMINT OIL BUCCAL FILM, SOLUBLE 0.85 mg MDE Replacement
5860 Q4 2021 PEPPERMINT OIL BUCCAL FILM, SOLUBLE 3 mg MDE Replacement
5875 Q3 2021 PEPPERMINT OIL SUBLINGUAL POWDER 0.40 mg MDE Replacement
5875 Q4 2021 PEPPERMINT OIL SUBLINGUAL POWDER 1.2 mg MDE Replacement
5928 Q3 2021 PHENOXYETHANOL TOPICAL CREAM 1.00 %w/w MDE Replacement
5928 Q4 2021 PHENOXYETHANOL TOPICAL CREAM 57 mg MDE Replacement
5938 Q3 2021 PHENYLETHYL ALCOHOL NASAL SPRAY, METERED 2.50 mg MDE Replacement
5938 Q4 2021 PHENYLETHYL ALCOHOL NASAL SPRAY, METERED 10 mg MDE Replacement
5995 Q3 2021 PLASACRYL T20 ORAL CAPSULE, EXTENDED RELEASE 3.98 mg MDE Replacement
5995 Q4 2021 PLASACRYL T20 ORAL CAPSULE, EXTENDED RELEASE 3.98 mg MDE Replacement
6001 Q3 2021 POLACRILIN POTASSIUM ORAL CAPSULE 45.28 mg MDE Replacement
6001 Q4 2021 POLACRILIN POTASSIUM ORAL CAPSULE 54.95 mg MDE Replacement
6003 Q3 2021 POLACRILIN POTASSIUM ORAL SUSPENSION 20.00 mg/ 5.00 ml MDE Replacement
6003 Q4 2021 POLACRILIN POTASSIUM ORAL SUSPENSION 120 mg MDE Replacement
6046 Q3 2021 POLOXAMER 407 ORAL CAPSULE, DELAYED RELEASE 5.00 mg MDE Replacement
6046 Q4 2021 POLOXAMER 407 ORAL CAPSULE, DELAYED RELEASE 5 mg MDE Replacement
6064 Q3 2021 POLYCARBOPHIL BUCCAL FILM, SOLUBLE 1.37 mg MDE Replacement
6064 Q4 2021 POLYCARBOPHIL BUCCAL FILM, SOLUBLE 5.48 mg MDE Replacement
6173 Q3 2021 POLYETHYLENE GLYCOL 400 INTRAVENOUS INJECTION 7470.00 mg MDE Replacement
6173 Q4 2021 POLYETHYLENE GLYCOL 400 INTRAVENOUS INJECTION 25013.3 mg MDE Replacement
6224 Q3 2021 POLYETHYLENE GLYCOL 4000 ORAL TABLET, FILM COATED 4.20 mg MDE Replacement
6224 Q4 2021 POLYETHYLENE GLYCOL 4000 ORAL TABLET, FILM COATED 4.5 mg MDE Replacement
6274 Q3 2021 POLYETHYLENE GLYCOL 8000 ORAL TABLET, EXTENDED RELEASE 144.60 mg MDE Replacement
6274 Q4 2021 POLYETHYLENE GLYCOL 8000 ORAL TABLET, EXTENDED RELEASE 242 mg MDE Replacement
6294 Q3 2021 POLYETHYLENE OXIDE 200000 ORAL TABLET 173.99 mg MDE Replacement
6294 Q4 2021 POLYETHYLENE OXIDE 200000 ORAL TABLET 347.98 mg MDE Replacement
6295 Q3 2021 POLYETHYLENE OXIDE 200000 ORAL TABLET, EXTENDED RELEASE 345.00 mg MDE Replacement
6295 Q4 2021 POLYETHYLENE OXIDE 200000 ORAL TABLET, EXTENDED RELEASE 460 mg MDE Replacement
6298 Q3 2021 POLYETHYLENE OXIDE 4000000 ORAL TABLET, EXTENDED RELEASE 188.10 mg MDE Replacement
6298 Q4 2021 POLYETHYLENE OXIDE 4000000 ORAL TABLET, EXTENDED RELEASE 250.8 mg MDE Replacement
6300 Q3 2021 POLYETHYLENE OXIDE 7000000 ORAL TABLET 132.66 mg MDE Replacement
6300 Q4 2021 POLYETHYLENE OXIDE 7000000 ORAL TABLET 265.32 mg MDE Replacement
6324 Q3 2021 POLYISOBUTYLENE (1100000 MW) TOPICAL SYSTEM 66.78 mg MDE Replacement
6324 Q4 2021 POLYISOBUTYLENE (1100000 MW) TOPICAL SYSTEM 66.78 mg MDE Replacement
6517 Q3 2021 POLYSORBATE 80 ORAL GRANULE, FOR SUSPENSION 15.00 mg MDE Replacement
6517 Q4 2021 POLYSORBATE 80 ORAL GRANULE, FOR SUSPENSION 125 mg MDE Replacement
6561 Q3 2021 POLYVINYL ACETATE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 25.82 mg MDE Replacement
6561 Q4 2021 POLYVINYL ACETATE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 38.74 mg MDE Replacement
6653 Q3 2021 POTASSIUM CHLORIDE ORAL TABLET, EXTENDED RELEASE 9.90 mg MDE Replacement
6653 Q4 2021 POTASSIUM CHLORIDE ORAL TABLET, EXTENDED RELEASE 13.2 mg MDE Replacement
6656 Q3 2021 POTASSIUM CITRATE ORAL POWDER, FOR SOLUTION 175.00 mg MDE Replacement
6656 Q4 2021 POTASSIUM CITRATE ORAL POWDER, FOR SOLUTION 490 mg MDE Replacement
6788 Q3 2021 POVIDONE K30 ORAL TABLET, CHEWABLE, EXTENDED RELEASE 8.18 mg MDE Replacement
6788 Q4 2021 POVIDONE K30 ORAL TABLET, CHEWABLE, EXTENDED RELEASE 12.28 mg MDE Replacement
6818 Q3 2021 POVIDONE K90 ORAL TABLET 78.00 mg MDE Replacement
6818 Q4 2021 POVIDONE K90 ORAL TABLET 525 mg MDE Replacement
6838 Q3 2021 POWDERED CELLULOSE ORAL TABLET 560.00 mg MDE Replacement
6838 Q4 2021 POWDERED CELLULOSE ORAL TABLET 1582.4 mg MDE Replacement
6843 Q3 2021 POWDERED CELLULOSE ORAL TABLET, FILM COATED 391.70 mg MDE Replacement
6843 Q4 2021 POWDERED CELLULOSE ORAL TABLET, FILM COATED 391.7 mg MDE Replacement
6867 Q3 2021 PROPYL GALLATE ORAL CAPSULE 2.00 mg MDE Replacement
6867 Q4 2021 PROPYL GALLATE ORAL CAPSULE 4 mg MDE Replacement
Q3 2021 PROPYLENE GLYCOL BUCCAL FILM, SOLUBLE 1.02 mg MDE Replacement
Q4 2021 PROPYLENE GLYCOL BUCCAL FILM, SOLUBLE 4 mg MDE Replacement
6887 Q3 2021 PROPYLENE GLYCOL INTRAMUSCULAR INJECTION, SOLUTION 41.60 %w/v MDE Replacement
6887 Q4 2021 PROPYLENE GLYCOL INTRAMUSCULAR INJECTION, SOLUTION 4000 mg MDE Replacement
6902 Q3 2021 PROPYLENE GLYCOL ORAL CAPSULE 148.31 mg MDE Replacement
6902 Q4 2021 PROPYLENE GLYCOL ORAL CAPSULE 700 mg MDE Replacement
6924 Q3 2021 PROPYLENE GLYCOL ORAL TABLET, FILM COATED 14.62 mg MDE Replacement
6924 Q4 2021 PROPYLENE GLYCOL ORAL TABLET, FILM COATED 154 mg MDE Replacement
6925 Q3 2021 PROPYLENE GLYCOL ORAL TABLET, FILM COATED, EXTENDED RELEASE 12.80 mg MDE Replacement
6925 Q4 2021 PROPYLENE GLYCOL ORAL TABLET, FILM COATED, EXTENDED RELEASE 19.2 mg MDE Replacement
6935 Q3 2021 PROPYLENE GLYCOL SUBLINGUAL SPRAY 4.50 mg/ 1.00 ml MDE Replacement
6935 Q4 2021 PROPYLENE GLYCOL SUBLINGUAL SPRAY 36 mg MDE Replacement
6943 Q3 2021 PROPYLENE GLYCOL TOPICAL GEL, METERED 35.00 %w/w MDE Replacement
6943 Q4 2021 PROPYLENE GLYCOL TOPICAL GEL, METERED 1225 mg MDE Replacement
6959 Q3 2021 PROPYLENE GLYCOL VAGINAL CREAM 20.00 %w/w MDE Replacement
6959 Q4 2021 PROPYLENE GLYCOL VAGINAL CREAM 400 mg MDE Replacement
Q3 2021 PROPYLPARABEN BUCCAL FILM, SOLUBLE 0.18 mg MDE Replacement
Q4 2021 PROPYLPARABEN BUCCAL FILM, SOLUBLE 0.72 mg MDE Replacement
7047 Q3 2021 PROPYLPARABEN TOPICAL GEL 0.05 %w/w MDE Replacement
7047 Q4 2021 PROPYLPARABEN TOPICAL GEL 1 mg MDE Replacement
7128 Q3 2021 SACCHARIN ORAL SYRUP 3.50 mg/ 5.00 ml MDE Replacement
7128 Q4 2021 SACCHARIN ORAL SYRUP 8 mg MDE Replacement
7138 Q3 2021 SACCHARIN SODIUM BUCCAL FILM 2.99 mg MDE Replacement
7138 Q4 2021 SACCHARIN SODIUM BUCCAL FILM 2.99 mg MDE Replacement
7139 Q3 2021 SACCHARIN SODIUM BUCCAL FILM, SOLUBLE 0.57 mg MDE Replacement
7139 Q4 2021 SACCHARIN SODIUM BUCCAL FILM, SOLUBLE 2 mg MDE Replacement
7206 Q3 2021 SESAME OIL ORAL CAPSULE 162.50 mg MDE Replacement
7206 Q4 2021 SESAME OIL ORAL CAPSULE 2325 mg MDE Replacement
7269 Q3 2021 SILICON DIOXIDE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 1.60 mg MDE Replacement
7269 Q4 2021 SILICON DIOXIDE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 2.4 mg MDE Replacement
7368 Q3 2021 SODIUM ACETATE INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 125.00 mg MDE Replacement
7368 Q4 2021 SODIUM ACETATE INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 125 mg MDE Replacement
7383 Q3 2021 SODIUM ACETATE SUBCUTANEOUS INJECTION 0.98%w/v MDE Replacement
7383 Q4 2021 SODIUM ACETATE SUBCUTANEOUS INJECTION 9.8 mg MDE Replacement
7420 Q3 2021 SODIUM BENZOATE BUCCAL FILM 0.96 mg MDE Replacement
7420 Q4 2021 SODIUM BENZOATE BUCCAL FILM 0.96 mg MDE Replacement
7421 Q3 2021 SODIUM BENZOATE BUCCAL FILM, SOLUBLE 0.69 mg MDE Replacement
7421 Q4 2021 SODIUM BENZOATE BUCCAL FILM, SOLUBLE 3 mg MDE Replacement
7555 Q3 2021 SODIUM CARBONATE ORAL GRANULE, FOR SUSPENSION 6.50 mg MDE Replacement
7555 Q4 2021 SODIUM CARBONATE ORAL GRANULE, FOR SUSPENSION 6.5 mg MDE Replacement
7561 Q3 2021 SODIUM CARBONATE ORAL TABLET, EXTENDED RELEASE 30.00 mg MDE Replacement
7561 Q4 2021 SODIUM CARBONATE ORAL TABLET, EXTENDED RELEASE 80 mg MDE Replacement
7584 Q3 2021 SODIUM CHLORIDE EPIDURAL INJECTION 24.00 %w/v MDE Replacement
7584 Q4 2021 SODIUM CHLORIDE EPIDURAL INJECTION 583.62 mg MDE Replacement
7585 Q3 2021 SODIUM CHLORIDE EPIDURAL INJECTION, SOLUTION 0.90 %w/v MDE Replacement
7585 Q4 2021 SODIUM CHLORIDE EPIDURAL INJECTION, SOLUTION 216.65 mg MDE Replacement
7597 Q3 2021 SODIUM CHLORIDE INTRACARDIAC INJECTION 0.70 %w/v MDE Replacement
7597 Q4 2021 SODIUM CHLORIDE INTRACARDIAC INJECTION 63 mg MDE Replacement
7623 Q3 2021 SODIUM CHLORIDE INTRATHECAL INJECTION, SOLUTION 0.90 %w/v MDE Replacement
7623 Q4 2021 SODIUM CHLORIDE INTRATHECAL INJECTION, SOLUTION 122.4 mg MDE Replacement
7656 Q3 2021 SODIUM CHLORIDE ORAL CAPSULE, EXTENDED RELEASE 20.72 mg MDE Replacement
7656 Q4 2021 SODIUM CHLORIDE ORAL CAPSULE, EXTENDED RELEASE 41.44 mg MDE Replacement
7672 Q3 2021 SODIUM CHLORIDE PARENTERAL INJECTION 24.00 %w/v MDE Replacement
7672 Q4 2021 SODIUM CHLORIDE PARENTERAL INJECTION 583.62 mg MDE Replacement
7845 Q3 2021 SODIUM HYDROXIDE ORAL TABLET, ORALLY DISINTEGRATING 0.16 mg MDE Replacement
7845 Q4 2021 SODIUM HYDROXIDE ORAL TABLET, ORALLY DISINTEGRATING 0.62 mg MDE Replacement
7942 Q3 2021 SODIUM LAURYL SULFATE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 0.30 mg MDE Replacement
7942 Q4 2021 SODIUM LAURYL SULFATE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 0.6 mg MDE Replacement
7964 Q3 2021 SODIUM LAURYL SULFATE VAGINAL CREAM 0.33 %w/w MDE Replacement
7964 Q4 2021 SODIUM LAURYL SULFATE VAGINAL CREAM 12 mg MDE Replacement
8016 Q3 2021 SODIUM OLEATE INTRAVENOUS INJECTION, EMULSION 0.48 %w/v MDE Replacement
8016 Q4 2021 SODIUM OLEATE INTRAVENOUS INJECTION, EMULSION 90 mg MDE Replacement
8075 Q3 2021 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS INTRA-ARTICULAR INJECTION 0.71 %w/v MDE Replacement
8075 Q4 2021 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS INTRA-ARTICULAR INJECTION 28.4 mg MDE Replacement
8077 Q3 2021 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS INTRALESIONAL INJECTION 0.71 %w/v MDE Replacement
8077 Q4 2021 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS INTRALESIONAL INJECTION 28.4 mg MDE Replacement
8095 Q3 2021 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS NASAL SPRAY, METERED 6.48 mg/ 1.00 ml MDE Replacement
8095 Q4 2021 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS NASAL SPRAY, METERED 7.1 mg MDE Replacement
8107 Q3 2021 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS ORAL TABLET, EXTENDED RELEASE 110.00 mg MDE Replacement
8107 Q4 2021 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS ORAL TABLET, EXTENDED RELEASE 210 mg MDE Replacement
8183 Q3 2021 SODIUM PHOSPHATE, MONOBASIC BUCCAL FILM, SOLUBLE 0.76 mg MDE Replacement
8183 Q4 2021 SODIUM PHOSPHATE, MONOBASIC BUCCAL FILM, SOLUBLE 3 mg MDE Replacement
8260 Q3 2021 SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE INTRA-ARTICULAR INJECTION 0.34 %w/v MDE Replacement
8260 Q4 2021 SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE INTRA-ARTICULAR INJECTION 13.6 mg MDE Replacement
8261 Q3 2021 SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE INTRALESIONAL INJECTION 0.68 %w/v MDE Replacement
8261 Q4 2021 SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE INTRALESIONAL INJECTION 13.6 mg MDE Replacement
8291 Q3 2021 SODIUM PHOSPHATE, TRIBASIC BUCCAL FILM, SOLUBLE 0.76 mg MDE Replacement
8291 Q4 2021 SODIUM PHOSPHATE, TRIBASIC BUCCAL FILM, SOLUBLE 3.04 mg MDE Replacement
8315 Q3 2021 SODIUM POLYSTYRENE SULFONATE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 83.18 mg MDE Replacement
8315 Q4 2021 SODIUM POLYSTYRENE SULFONATE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 124.78 mg MDE Replacement
8447 Q3 2021 SORBIC ACID ORAL TABLET, FILM COATED 0.94 mg MDE Replacement
8447 Q4 2021 SORBIC ACID ORAL TABLET, FILM COATED 5 mg MDE Replacement
8448 Q3 2021 SORBIC ACID ORAL TABLET, FILM COATED, EXTENDED RELEASE 0.40 mg MDE Replacement
8448 Q4 2021 SORBIC ACID ORAL TABLET, FILM COATED, EXTENDED RELEASE 0.8 mg MDE Replacement
8474 Q3 2021 SORBITAN MONOOLEATE ORAL TABLET 1.70 mg MDE Replacement
8474 Q4 2021 SORBITAN MONOOLEATE ORAL TABLET 6.27 mg MDE Replacement
8478 Q3 2021 SORBITAN MONOOLEATE ORAL TABLET, FILM COATED 1.70 mg MDE Replacement
8478 Q4 2021 SORBITAN MONOOLEATE ORAL TABLET, FILM COATED 12 mg MDE Replacement
8479 Q3 2021 SORBITAN MONOOLEATE ORAL TABLET, FILM COATED, EXTENDED RELEASE 1.00 mg MDE Replacement
8479 Q4 2021 SORBITAN MONOOLEATE ORAL TABLET, FILM COATED, EXTENDED RELEASE 2 mg MDE Replacement
8629 Q3 2021 STARCH ORAL TABLET 1000.00 mg MDE Replacement
8629 Q4 2021 STARCH ORAL TABLET 2440 mg MDE Replacement
8681 Q3 2021 STARCH, POTATO ORAL TABLET 80.59 mg MDE Replacement
8681 Q4 2021 STARCH, POTATO ORAL TABLET 458.4 mg MDE Replacement
8743 Q3 2021 STEARIC ACID ORAL TABLET, EXTENDED RELEASE 187.50 mg MDE Replacement
8743 Q4 2021 STEARIC ACID ORAL TABLET, EXTENDED RELEASE 200 mg MDE Replacement
8744 Q3 2021 STEARIC ACID ORAL TABLET, FILM COATED 22.00 mg MDE Replacement
8744 Q4 2021 STEARIC ACID ORAL TABLET, FILM COATED 176 mg MDE Replacement
8781 Q3 2021 STEARYL ALCOHOL VAGINAL CREAM 8.50 %w/w MDE Replacement
8781 Q4 2021 STEARYL ALCOHOL VAGINAL CREAM 280 mg MDE Replacement
8790 Q3 2021 STYRENE/ISOPRENE/STYRENE BLOCK COPOLYMER TOPICAL SYSTEM 519.75 mg MDE Replacement
8790 Q4 2021 STYRENE/ISOPRENE/STYRENE BLOCK COPOLYMER TOPICAL SYSTEM 519.75 mg MDE Replacement
8796 Q3 2021 SUCCINIC ACID ORAL POWDER, FOR SUSPENSION 1.00 mg MDE Replacement
8796 Q4 2021 SUCCINIC ACID ORAL POWDER, FOR SUSPENSION 5.01 mg MDE Replacement
8810 Q3 2021 SUCRALOSE ORAL POWDER, FOR SOLUTION 41.40 mg MDE Replacement
8810 Q4 2021 SUCRALOSE ORAL POWDER, FOR SOLUTION 82.6 mg MDE Replacement
8812 Q3 2021 SUCRALOSE ORAL SOLUTION 230.00 mg MDE Replacement
8812 Q4 2021 SUCRALOSE ORAL SOLUTION 800 mg MDE Replacement
8829 Q3 2021 SUCROSE INTRAVENOUS INJECTION, EMULSION 5.40 %w/v MDE Replacement
8829 Q4 2021 SUCROSE INTRAVENOUS INJECTION, EMULSION 970 mg MDE Replacement
8952 Q3 2021 TALC ORAL TABLET, CHEWABLE, EXTENDED RELEASE 12.00 mg MDE Replacement
8952 Q4 2021 TALC ORAL TABLET, CHEWABLE, EXTENDED RELEASE 18 mg MDE Replacement
8959 Q3 2021 TALC ORAL TABLET, FILM COATED, EXTENDED RELEASE 30.00 mg MDE Replacement
8959 Q4 2021 TALC ORAL TABLET, FILM COATED, EXTENDED RELEASE 60 mg MDE Replacement
8986 Q3 2021 TARTARIC ACID ORAL TABLET, FOR SUSPENSION 7.00 mg MDE Replacement
8986 Q4 2021 TARTARIC ACID ORAL TABLET, FOR SUSPENSION 28 mg MDE Replacement
9009 Q3 2021 TERT-BUTYLHYDROQUINONE VAGINAL CREAM 0.02 %w/w MDE Replacement
9009 Q4 2021 TERT-BUTYLHYDROQUINONE VAGINAL CREAM 0.8 mg MDE Replacement
9033 Q3 2021 TITANIUM DIOXIDE BUCCAL FILM, SOLUBLE 2.78 mg MDE Replacement
9033 Q4 2021 TITANIUM DIOXIDE BUCCAL FILM, SOLUBLE 2.78 mg MDE Replacement
9051 Q3 2021 TITANIUM DIOXIDE ORAL SUSPENSION 75 mg Correction
9051 Q4 2021 TITANIUM DIOXIDE ORAL SUSPENSION 80 mg Correction
9057 Q3 2021 TITANIUM DIOXIDE ORAL TABLET, FILM COATED 24.23 mg MDE Replacement
9057 Q4 2021 TITANIUM DIOXIDE ORAL TABLET, FILM COATED 36 mg MDE Replacement
9099 Q3 2021 TRIACETIN ORAL TABLET, CHEWABLE, EXTENDED RELEASE 1.36 mg MDE Replacement
9099 Q4 2021 TRIACETIN ORAL TABLET, CHEWABLE, EXTENDED RELEASE 2.04 mg MDE Replacement
9136 Q3 2021 TRIETHYL CITRATE ORAL GRANULE, FOR SUSPENSION 6.94 mg MDE Replacement
9136 Q4 2021 TRIETHYL CITRATE ORAL GRANULE, FOR SUSPENSION 6.94 mg MDE Replacement
9158 Q3 2021 TRISODIUM CITRATE DIHYDRATE INTRACARDIAC INJECTION 0.21 %w/v MDE Replacement
9158 Q4 2021 TRISODIUM CITRATE DIHYDRATE INTRACARDIAC INJECTION 18.63 mg MDE Replacement
9191 Q3 2021 TRISODIUM CITRATE DIHYDRATE SUBCUTANEOUS INJECTION 0.63 %w/v MDE Replacement
9191 Q4 2021 TRISODIUM CITRATE DIHYDRATE SUBCUTANEOUS INJECTION 18.63 mg MDE Replacement
9215 Q3 2021 TROLAMINE TOPICAL GEL, METERED 1.00 %w/w MDE Replacement
9215 Q4 2021 TROLAMINE TOPICAL GEL, METERED 19.25 mg MDE Replacement
9245 Q3 2021 TROMETHAMINE ORAL CAPSULE 15.00 mg MDE Replacement
9245 Q4 2021 TROMETHAMINE ORAL CAPSULE 30 mg MDE Replacement
9286 Q3 2021 VANILLIN ORAL TABLET 1.50 mg MDE Replacement
9286 Q4 2021 VANILLIN ORAL TABLET 4.5 mg MDE Replacement
9292 Q3 2021 VANILLIN ORAL TABLET, FILM COATED 0.94 mg MDE Replacement
9292 Q4 2021 VANILLIN ORAL TABLET, FILM COATED 5 mg MDE Replacement
9293 Q3 2021 VANILLIN ORAL TABLET, FILM COATED, EXTENDED RELEASE 0.80 mg MDE Replacement
9293 Q4 2021 VANILLIN ORAL TABLET, FILM COATED, EXTENDED RELEASE 0.8 mg MDE Replacement
9309 Q3 2021 VEGETABLE OIL, HYDROGENATED ORAL TABLET 40.00 mg MDE Replacement
9309 Q4 2021 VEGETABLE OIL, HYDROGENATED ORAL TABLET 42 mg MDE Replacement
9335 Q3 2021 WHITE PETROLATUM TOPICAL CREAM 15.00 %w/w MDE Replacement
9335 Q4 2021 WHITE PETROLATUM TOPICAL CREAM 798 mg MDE Replacement
9357 Q3 2021 XANTHAN GUM ORAL GRANULE, FOR SUSPENSION 259.40 mg MDE Replacement
9357 Q4 2021 XANTHAN GUM ORAL GRANULE, FOR SUSPENSION 450 mg MDE Replacement
9369 Q3 2021 XANTHAN GUM ORAL TABLET, CHEWABLE, EXTENDED RELEASE 4.00 mg MDE Replacement
9369 Q4 2021 XANTHAN GUM ORAL TABLET, CHEWABLE, EXTENDED RELEASE 6 mg MDE Replacement
9379 Q3 2021 XANTHAN GUM TOPICAL CREAM 0.75 %w/w MDE Replacement
9379 Q4 2021 XANTHAN GUM TOPICAL CREAM 45.6 mg MDE Replacement
9383 Q3 2021 XYLITOL BUCCAL GUM, CHEWING 506.13 mg MDE Replacement
9383 Q4 2021 XYLITOL BUCCAL GUM, CHEWING 9542.6 mg MDE Replacement
9394 Q3 2021 XYLITOL SUBLINGUAL SPRAY 2.70 mg/ 1.00 ml MDE Replacement
9394 Q4 2021 XYLITOL SUBLINGUAL SPRAY 21.6 mg MDE Replacement
127 Q4 2021 ACETYLTRIBUTYL CITRATE TOPICAL SPONGE 5.40 %w/w Deletion
448 Q4 2021 ANHYDROUS TRISODIUM CITRATE ORAL SYRUP 7.95 mg/ 5.00 ml Deletion
725 Q4 2021 BORIC ACID ORAL SOLUTION/ DROPS 15.00 mg/ 1.00 ml Deletion
2120 Q4 2021 EDETATE DISODIUM ORAL SOLUTION/ DROPS 1.00 mg/ 1.00 ml Deletion
2393 Q4 2021 FD&C BLUE NO. 1 TOPICAL SPONGE 0.01 %w/w Deletion
2551 Q4 2021 FD&C YELLOW NO. 5 TOPICAL SPONGE 0.06 %w/w Deletion
3487 Q4 2021 HYDROGENATED SOYBEAN LECITHIN INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL 0.96 %w/v Deletion
3496 Q4 2021 HYDROLYZED SOY PROTEIN (ENZYMATIC; 2000 MW) INTRAVENOUS INJECTABLE, LIPOSOMAL 0.96 %w/v Deletion
3641 Q4 2021 HYPROMELLOSE NASAL SPRAY, METERED 1.00 mg/ 1.00 ml Deletion
3678 Q4 2021 HYPROMELLOSE 2208 (100 MPA.S) BUCCAL TABLET, DELAYED RELEASE 17.25 mg Deletion
3684 Q4 2021 HYPROMELLOSE 2208 (100000 MPA.S) ORAL TABLET, FILM COATED 536.80 mg Deletion
3833 Q4 2021 HYPROMELLOSE PHTHALATE ORAL CAPSULE 48.10 mg Deletion
3851 Q4 2021 HYPROMELLOSE PHTHALATE ORAL TABLET, FILM COATED 23.10 mg Deletion
3861 Q4 2021 HYPROMELLOSE PHTHALATE ORAL TABLET, DELAYED RELEASE 16.42 mg Deletion
3942 Q4 2021 ISOOCTYL ACRYLATE/ACRYLAMIDE/VINYL ACETATE COPOLYMER, KOLLIDON VA 64 POLYMER ORAL TABLET, FILM COATED 53.00 mg Deletion
4360 Q4 2021 MAGNESIUM STEARATE BUCCAL TABLET, DELAYED RELEASE 0.58 mg 1 mg Deletion
4710 Q4 2021 METHYLCELLULOSE VAGINAL TABLET 102.00 mg Deletion
4814 Q4 2021 MICROCRYSTALLINE CELLULOSE BUCCAL TABLET, DELAYED RELEASE 18.04 mg Deletion
4853 Q4 2021 MILK PROTEIN CONCENTRATE BUCCAL TABLET, DELAYED RELEASE 23.00 mg 23 mg Deletion
5459 Q4 2021 OPADRY YS-1-14142 PINK ORAL TABLET, FILM COATED, EXTENDED RELEASE 16.00 mg 26.8 mg Deletion
5616 Q4 2021 OPADRY YS-2-19114A CLEAR ORAL TABLET, EXTENDED RELEASE 1.50 mg Deletion
5645 Q4 2021 OPALUX AS 2553 ORANGE ORAL TABLET NA Deletion
5654 Q4 2021 OPALUX AS 5034 RED ORAL TABLET, COATED 0.02 mg Deletion
6263 Q4 2021 POLYETHYLENE GLYCOL 6000 VAGINAL INSERT 0.10 mg Deletion
6359 Q4 2021 POLYOXYL 35 CASTOR OIL ORAL SOLUTION/ DROPS 50.00 mg/ 1.00 ml Deletion
6589 Q4 2021 POLYVINYL ALCOHOL VAGINAL TABLET 20.60 mg Deletion
6760 Q4 2021 POVIDONE K27 ORAL TABLET 26.60 mg Deletion
6762 Q4 2021 POVIDONE K30 BUCCAL TABLET, DELAYED RELEASE 0.50 mg 0.5 mg Deletion
7239 Q4 2021 SILICON DIOXIDE BUCCAL TABLET, DELAYED RELEASE 0.46 mg Deletion
8440 Q4 2021 SORBIC ACID ORAL SOLUTION/ DROPS 2.00 mg/ 1.00 ml Deletion
9204 Q4 2021 TRISODIUM HEDTA TOPICAL SPONGE 0.01 %w/w Deletion
9247 Q4 2021 TROMETHAMINE ORAL SOLUTION/ DROPS 7.60 mg/ 1.00 ml Deletion

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: September 30, 2021
Database Last Updated: October 21, 2021

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English